Complementary studies on other NRAS mutant melanoma cell lines are required to show that such high TRT radiosensitivity is related to NRAS mutation, although previous EBRT studies have reported increased radiosensitivity in vitro [47] and in vivo [48] when NRAS is mutated. The gene discussed is NRAS; the disease is melanoma.